Anzeige
Mehr »
Mittwoch, 13.05.2026 - Börsentäglich über 12.000 News
Bahnbrechende KI-Lösung "Ohne Nadelstiche" als Ersatz für herkömmliche Bluttests "unlocked"?!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
663 Leser
Artikel bewerten:
(2)

Radiological Society of North America (RSNA): AI Model Analyses Body Composition to Predict Health Risks

OAK BROOK, Ill., May 5, 2026 /PRNewswire/ -- Researchers used AI to analyze whole-body MRI scans from more than 66,000 participants to create the most detailed reference map to date of how fat and muscle are distributed in the human body across age, sex and height. The study was published today in Radiology, a journal of the Radiological Society of North America (RSNA). Results of the study show that the quality and amount of skeletal muscle, not just visceral fat, are strong predictors of diabetes, major cardiovascular events and mortality.

Clinicians have long relied on body mass index (BMI) and body weight to estimate cardiometabolic-the connection between cardiovascular (heart/blood vessel) and metabolic (energy/nutrient processing) systems on health-and overall health risk. But BMI is a crude measure of body composition that only relies on height and weight and does not account for muscle mass or fat distribution.

"Many risk scores and treatment decisions still rely on BMI or waist circumference because they are simple to obtain," said senior author Jakob Weiss, M.D., Ph.D., radiologist in the Department of Diagnostic and Interventional Radiology at University Medical Center Freiburg in Germany. "But BMI does not reliably reflect a person's actual body composition."

Dr. Weiss said the medical community also lacks reference standards for how body composition changes in asymptomatic individuals as they age, as well as differences between men and women.

"There is growing evidence that body composition measures are independent risk factors for cardiometabolic and oncological diseases and mortality," said first author Matthias Jung, M.D., from the Department of Diagnostic and Interventional Radiology, University Medical Center Freiburg. "However, these measures are influenced by height and sex and change substantially with age."

The retrospective study included a cohort of 66,608 individuals (mean age 57.7 years, 34,443 males, mean BMI: 26.2) who underwent whole-body MRI as participants in the UK Biobank and the German National Cohort between April 2014 and May 2022.

The researchers calculated age-, sex-, and height-normalized body composition metrics from the MRI scans using their open-source, fully automated deep learning framework. The body composition metrics, including subcutaneous adipose tissue, visceral adipose tissue, skeletal muscle, skeletal muscle fat fraction, and intramuscular adipose tissue, were expressed as z-scores, which show how far an individual deviated from the age-, sex-, and height-adjusted norm.

The researchers then conducted statistical analyses to assess the prognostic value of z-score categories (low: z<-1; middle: z=-1 to 1; high: z>1) to predict the incidence of diabetes, major adverse cardiovascular events and all-cause mortality.

They found that high visceral fat was associated with a 2.26-fold increased risk of future diabetes, high intramuscular fat was associated with a 1.54-fold increased risk of future major cardiovascular events, and low skeletal muscle was associated with a 1.44-fold higher all-cause mortality beyond cardiometabolic risk factors.

"It's not only how much muscle you have, but also it's the quality of that muscle," Dr. Jung said. "Knowing the volume of intramuscular fat gives us a window into muscle quality that other methods like BMI, bioelectrical impedance analysis, or DEXA can't easily provide."

The research team also generated age-, sex-, and height-normalized reference curves for key body composition measures.

"Adjusting for confounding factors is critical for improving screening accuracy and tailoring treatment decisions," Dr. Weiss said. "This tool has the potential to identify whether an individual's body composition puts them at greater risk for metabolic disease compared to their age-matched peers."

The researchers released their open-source web-based age-, sex-, and height-adjusted body composition z-score calculator to support future research, accelerate clinical translation, enabling researchers and clinicians to normalize their own datasets for improved comparability and generalizability.

"This tool can allow clinicians to use routine imaging opportunistically," Dr. Weiss said. "A dedicated whole-body MRI is not necessarily required. If a routine CT or MRI body scan already exists, the information can be extracted for benchmarking against the reference values."

Dr. Weiss said the AI tool could also help improve risk stratification in oncology or distinguish desirable fat loss from unwanted muscle loss in patients using weight-loss drugs such as GLP-1 agonists.

"We're already imaging patients every day," Dr. Weiss noted. "On every scan of the abdomen or chest, the information is there, we just don't routinely measure or report it. AI now allows us to tap into this hidden layer of data in a quantitative, reproducible way."

Next steps for the researchers include validating the reference curves in clinical populations, especially predicting treatment toxicity, survival and recurrence in cancer patients, and developing disease-specific reference values for other patient groups.

"Body Composition in the General Population: Whole-body MRI-derived Reference Curves from Over 66,000 Individuals." Collaborating with Drs. Weiss and Jung were Marco Reisert, Ph.D., Hanna Rieder, Susanne Rospleszcz, Ph.D., Tobias Haueise, Ph.D., Tobias Pischon, Ph.D., Thoralf Niendorf, Ph.D., Hans-Ulrich Kauczor, M.D., Henry Völzke, M.D., Robin Bülow, M.D., Maximilian F. Russe, M.D., Christopher L. Schlett, M.D., M.P.H., Michael T. Lu, M.D., M.P.H., Fabian Bamberg, M.D., M.P.H., and Vineet K. Raghu, Ph.D.

Radiology is edited by Suhny Abbara, M.D., FACR, MSCCT, Mayo Clinic, Jacksonville, Florida, and owned and published by the Radiological Society of North America, Inc. (https://pubs.rsna.org/journal/radiology)

RSNA is an association of radiologists, radiation oncologists, medical physicists and related scientists promoting excellence in patient care and health care delivery through education, research and technologic innovation. The Society is based in Oak Brook, Illinois. (RSNA.org)

For patient-friendly information on MRI, visit RadiologyInfo.org.

Logo - https://mma.prnewswire.com/media/2285186/New_RSNA_Signature_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/ai-model-analyses-body-composition-to-predict-health-risks-302762398.html

© 2026 PR Newswire
Vergessen Sie Gold, Silber und Öl: Nächste Megarallye startet!
Die Märkte feiern neue Rekorde – doch im Hintergrund braut sich eine Entwicklung zusammen, die alles verändern könnte. Die anhaltende Sperrung der Straße von Hormus sorgt laut IEA für eine der größten Energiekrisen aller Zeiten. Gleichzeitig schießen die Preise für Düngemittel und Agrarrohstoffe bereits nach oben.

Damit droht ein perfekter Sturm: steigende Energiepreise, explodierende Produktionskosten und ein möglicher Super-El-Nino, der weltweit Ernten gefährdet. Erste Auswirkungen sind längst sichtbar – Weizen, Soja und Kakao verteuern sich deutlich, während Lebensmittelpreise vor dem nächsten Sprung stehen könnten.

Für Anleger bedeutet das nicht nur Risiken, sondern enorme Chancen. Denn während klassische Märkte unter Druck geraten könnten, entsteht auf den Feldern und Plantagen der nächste große Rohstoffzyklus. Wer sich jetzt richtig positioniert, kann von einer Entwicklung profitieren, die weit über Öl und Metalle hinausgeht.

In unserem aktuellen Spezialreport stellen wir drei Aktien vor, die besonders aussichtsreich sind, um von diesem Trend zu profitieren – solide positioniert, strategisch relevant und mit erheblichem Aufwärtspotenzial.



Jetzt den kostenlosen Report sichern – bevor der Agrar-Boom voll durchschlägt!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.